Global Influenza Vaccines Market 2021 – 2027

The number of persons being vaccinated with influenza vaccines worldwide will touch the figure of 500 Million by the year-end of 2027.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccines, the introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most of the countries.

Long–term Growth Projection:

The global influenza vaccines market size is set to surpass US$ 6.5 Billion by the year-end of 2021
Influenza vaccines demand is expected to increase in the forecast period
The United States influenza vaccines market is projected to grow with a significant CAGR in the forecast period
In Japan, the influenza vaccines market holds a rewarding growth opportunity for the future as the demand for the vaccine is growing significantly
The Chinese influenza vaccines market is expected to record a value of nearly US$ 180 Million by the year-end of 2027
Europe is anticipated to be the fastest-growing market during the forecast period
The United Kingdom and Germany are the leading revenue generators of the market
Emerging players backed by technological advancements are developing vaccines that offer a more realistic experience

Key Features of the Study:

The Market Size of the Global Influenza Vaccines Market with Six Years Forecast
The Market Size of the Regional and National Influenza Vaccines Market with Six Years Forecast
Scrutinizes the Global Overall Persons Being Vaccinated with Influenza Vaccines
Scrutinizes the Regional and National Persons Being Vaccinated with Influenza Vaccines
Delivers a Latest Happenings in the Global Influenza Vaccines Market
Detailed Insights of the Regulatory Framework Including the Approval Process and an Overview of the Regulatory Authorities in the United States, EU, and Japan
Provides Key Trends with Respect to Collaboration Deals, Merger & Acquisitions, Distribution, Exclusive and Licensing Agreement
Reviews Most Recent Clinical Trials of the Influenza Vaccines
A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Sales Value Analysis, and Recent Development
An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development

The Report Analyses the Market Based on Countries and Presents the Forecast in Terms of Value and Volume for the Next Six Years. Twenty-One Major Markets(21MM) Covered in the Report are as follows:

United States
Canada
Brazil
Germany
France
Italy
Spain
United Kingdom
Netherlands
Sweden
Denmark
Poland
Norway
Finland
Ireland
Belgium
Australia
New Zealand
Japan
China
India

The Report Provides a Comprehensive Analysis of Company Profiles Listed Below:

Sanofi Pasteur
GlaxoSmithKline (GSK)
Seqirus (CSL Limited)
AstraZeneca
Mylan
BioDiem
Novavax
Medicago
Moderna Inc
Pneumagen
Daiichi–Sankyo
Altimmune
FluGen
Imutex
EpiVax
Versatope Therapeutics, Inc.
Gamma Vaccines Pty Ltd.
BiondVax Pharmaceuticals Ltd.
Hualan Biological Engineering Inc.
Shanghai Institute of Biological Products Co., Ltd.

The Report Answers Questions Such As:

What is the current size of the global influenza vaccines market? How much will this market be worth from 2020 to 2027?
How many persons being vaccinated with influenza vaccines globally during 2015 – 2027?
Which country is expected to hold the highest market share in the global influenza vaccine market?
What are the main drivers and restraints in the global influenza vaccines market?
What are the major deals happenings in the global influenza vaccines market?
Who are the top players and what are their activities, revenue, recent developments, and prospects?
What are some of the most prominent influenza vaccines currently in development? What are their activities, phase, platform technology, and recent developments?

More Information @ https://dpiresearch.com/reports/global-influenza-vaccines-market-analysis/

Maria Rai
Head of Business Development
New Delhi,India,
Web: https://dpiresearch.com
Direct Line: +91-766-764-8693
E-mail: sales@dpiresearch.com

DPI Research is a leading market research publisher that offers bespoke market research reports, custom research and consulting services across multi geographies and industry verticals.

To cater to the customers’ needs, DPI Research customizes the research data to each business inquiry and creates first-class reports that contain unique analytical findings and solutions.

This release was published on openPR.